Old Web
English
Sign In
Acemap
>
authorDetail
>
Ping bo Feng
Ping bo Feng
Cetuximab
Carcinoma
Chemoradiotherapy
Medicine
Pathology
4
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cetuximab combined with concurrent chemoradiotheray in Chinese patients with unresectable, locally advanced esophageal squamous cell carcinoma: A prospective, multicenter phase II trial.
2017
Journal of Clinical Oncology
Xue Meng
Jianhua Wang
X. Sun
L. Wang
Ming Ye
Ping bo Feng
G Zhu
You Lu
C. Han
Shu chai Zhu
Zhongxing X. Liao
Jinming Yu
Show All
Source
Cite
Save
Citations (0)
Cetuximab, paclitaxel, cisplatin and concurrent radiation in Chinese patients with locally advanced esophageal squamous cell carcinoma: An open-label, multicenter, phase II study.
2012
Journal of Clinical Oncology
Jinming Yu
Xue Meng
Jianhua Wang
Xindong Sun
Lv Hua Wang
Ming Ye
Ping bo Feng
Guang ying Zhu
You Lu
C. Han
Shu chai Zhu
Zhongxing X. Liao
Show All
Source
Cite
Save
Citations (1)
KRAS mutation status and toxicity of cetuximab, paclitaxel, cisplatin, and concurrent radiation in Chinese patients with locally advanced esophageal squamous cell carcinoma: An open-label, multicenter, phase II study.
2011
Journal of Clinical Oncology
Jinming Yu
Xue Meng
Jun Wang
Xindong Sun
L. Wang
Ming Ye
Ping bo Feng
G Zhu
You Lu
Shu chai Zhu
Show All
Source
Cite
Save
Citations (0)
An open label, multicenter clinical study of cetuximab combined with concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: Preliminary results of a phase II trial.
2010
Journal of Clinical Oncology
J.-M. Yu
Jun Wang
Xindong Sun
L.H. Wang
G Zhu
Ping bo Feng
Ming Ye
You Lu
Shu chai Zhu
Z. Liao
Show All
Source
Cite
Save
Citations (1)
1